Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
2,114
$138.79
$293.39K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
6,034
$137.63
$830.47K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
7,052
$136.83
$964.95K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
3,400
$135.44
$460.51K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
1,000
$134.38
$134.38K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
400
$133.12
$53.25K
Aaron Freidin
5 Oct 2026
Chief Financial Officer
Sell
23,619
$146.39
$3.46M
Andrew John Partridge
5 Oct 2026
Chief Growth Officer
Sell
7,873
$146.39
$1.15M
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
10,000
$110.00
$1.10M
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
2,100
$100.68
$211.43K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
421
$99.85
$42.04K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
1,400
$97.84
$136.98K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
6,200
$96.43
$597.87K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
37,752
$94.98
$3.59M
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
1,454
$93.61
$136.10K
Joshua J. Ofman
21 Sep 2026
Chief Executive Officer
Sold after exercise
2,125
$92.32
$196.17K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
521
$95.00
$49.50K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,800
$93.92
$169.05K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,779
$92.26
$164.14K
Aaron Freidin
27 Aug 2026
Chief Financial Officer
Sold on a plan
7,900
$85.01
$671.58K
Joshua J. Ofman
27 Aug 2026
Chief Executive Officer
Sold on a plan
5,000
$85.02
$425.10K
Andrew John Partridge
4 Jun 2026
Chief Growth Officer
Sell
1,491
$61.08
$91.07K
Joshua J. Ofman
8 Apr 2026
President
Sell
61,665
$49.92
$3.08M
Robert P Ragusa
8 Apr 2026
Chief Executive Officer
Sell
123,502
$49.92
$6.16M
Aaron Freidin
8 Apr 2026
Chief Financial Officer
Sell
45,806
$49.92
$2.29M
Robert P Ragusa
9 Mar 2026
Chief Executive Officer
Sell
258
$46.73
$12.06K
Robert P Ragusa
9 Mar 2026
Chief Executive Officer
Sell
7,203
$47.93
$345.24K
Joshua J. Ofman
9 Mar 2026
President
Sell
101
$46.74
$4.72K
Joshua J. Ofman
9 Mar 2026
President
Sell
2,836
$47.93
$135.93K
Aaron Freidin
9 Mar 2026
Chief Financial Officer
Sell
85
$46.74
$3.97K
Aaron Freidin
9 Mar 2026
Chief Financial Officer
Sell
2,407
$47.93
$115.37K
Robert P Ragusa
5 Mar 2026
Chief Executive Officer
Sell
980
$53.01
$51.95K
Joshua J. Ofman
5 Mar 2026
President
Sell
690
$53.01
$36.58K
Aaron Freidin
5 Mar 2026
Chief Financial Officer
Sell
655
$53.01
$34.72K
Robert P Ragusa
2 Mar 2026
Chief Executive Officer
Sell
1,717
$51.84
$89.01K
Robert P Ragusa
2 Mar 2026
Chief Executive Officer
Sell
35,787
$50.09
$1.79M
Aaron Freidin
2 Mar 2026
Chief Financial Officer
Sell
438
$51.86
$22.72K
Aaron Freidin
2 Mar 2026
Chief Financial Officer
Sell
9,135
$50.09
$457.53K
Joshua J. Ofman
2 Mar 2026
President
Sell
16,223
$50.09
$812.53K
Joshua J. Ofman
2 Mar 2026
President
Sell
779
$51.75
$40.31K
Aaron Freidin
3 Dec 2025
Chief Financial Officer
Sell
25,000
$99.15
$2.48M
Robert P Ragusa
3 Dec 2025
Chief Executive Officer
Sell
1,604
$97.28
$156.04K
Robert P Ragusa
3 Dec 2025
Chief Executive Officer
Sell
8,233
$96.22
$792.15K
Robert P Ragusa
3 Dec 2025
Chief Executive Officer
Sell
15,356
$95.28
$1.46M
Robert P Ragusa
3 Dec 2025
Chief Executive Officer
Sell
14,807
$94.43
$1.40M
Joshua J. Ofman
3 Dec 2025
President
Sell
13,000
$100.00
$1.30M
Illumina, Inc.
17 Nov 2025
10% owner
Sell
1,000,000
$79.85
$79.85M
Aaron Freidin
17 Nov 2025
Chief Financial Officer
Sell
1,697
$79.20
$134.40K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 8
Sales at will 29
Transactions with no price 0
Shares from compensation/vesting 227,821
History held since 24 Jun 2024